Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oral salbutamol decreases serum digoxin concentration

  • 26 Accesses

  • 2 Citations

Summary

The effect of a therapeutic dose of oral salbutamol on serum and skeletal muscle digoxin concentrations has been studied in volunteers digitalised with digoxin. On one occasion a biopsy was taken from the quadriceps after 2 h of supine rest and then 3–4 mg salbutamol was given orally. Blood samples were taken before and after that dose and another muscle biopsy specimen was taken from the same thigh 180 min after the medication. On another occasion control blood sampling, ECG and blood pressure recordings were made but without muscle biopsies or salbutamol administration.

Compared to the control measurements, salbutamol decreased the serum digoxin concentration (0.30 nmol·1−1). It also reduced the serum potassium concentration (0.58 mmol·1−1).

The digoxin concentration in skeletal muscle did not change significantly after the intake of salbutamol. Thus, even a therapeutic oral dose of salbutamol reduces the serum digoxin concentration in man.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Kjeldsen K (1986) The importance of skeletal muscles as a distribution volume for digitalis glycosides in guinea pigs and human subjects. In: Erdmann E, Greef K, Skou IC (eds) Cardiac Glycosides 1785–1985. Steinkopff, Darmstadt, pp 245–256

  2. 2.

    Edner M, Jogestrand T (1989) Effect of salbutamol on digoxin concentration in serum and skeletal muscle. Eur J Clin Pharmacol 36: 235–238

  3. 3.

    Jogestrand T, Nordlander R (1983) Serum digoxin determination in outpatients — need for standardization. Br J Clin Pharmacol 15: 55–58

  4. 4.

    Bergström J (1962) Muscle electrolytes in man. Scand J Clin Lab Invest 14 [Suppl 68]: 1–110

  5. 5.

    Smith TW, Butler VP, Haber E (1969) Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med 281: 1212–1216

  6. 6.

    Jogestrand T (1980) digoxin concentration in right atrial myocardium, skeletal muscle and serum in man — influence of atrial rhythm. Eur J Clin Pharmacol 17: 243–250

  7. 7.

    Willner BJ (1971) Statistical principles in experimental design. Mc Graw-Hill, New York, USA

  8. 8.

    Jogestrand T, Sundqvist K (1981) Effect of physical exercise on the digoxin concentrations in skeletal muscle and serum in man. Clin Physiol 1: 99–104

  9. 9.

    Joreteg T, Jogestrand T (1983) Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity. Eur J Clin Pharmacol 25: 585–588

  10. 10.

    Joreteg T, Jogestrand T (1986) Beta-blockade and binding of digoxin to skeletal muscle. Clin Physiol 6: 183–190

  11. 11.

    Clausen T, Flatman JA (1980) Beta2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. Br J Pharmacol 68: 749–755

  12. 12.

    Steiness E (1978) Digoxin. Klinisk farmakologi. Dissertation, University of Copenhagen, Copenhagen, Denmark

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Edner, M., Jogestrand, T. Oral salbutamol decreases serum digoxin concentration. Eur J Clin Pharmacol 38, 195–197 (1990). https://doi.org/10.1007/BF00265984

Download citation

Key words

  • Salbutamol
  • digoxin
  • beta2-adrenoceptor stimulation
  • serum digoxin
  • skeletal muscle digoxin concentration
  • drug interaction
  • healthy volunteers